Lombard Medical Technologies PLC Holding(s) in Company (5955H)

TIDMLMT

RNS Number : 5955H

Lombard Medical Technologies PLC

21 June 2013

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 
 1. Identity of the issuer or the underlying           Lombard Medical Technologies PLC 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
--------------------------------------------------  ----------------------------------- 
 2. Reason for the notification (please tick the appropriate box or boxes): 
--------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                       X 
------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
------------------------------------------------------------------------------  ------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------------------  ------- 
 Other (please 
  specify): 
------------------  ----------------------------------------------------------  ------- 
 3. Full name of person(s) subject           Abingworth LLP 
  to the                                      Abingworth Bioventures V Co-Invest 
  notification obligation: (iii)              Growth Equity Fund LP ("AGE") 
------------------------------------------  ------------------------------------------- 
 4. Full name of shareholder(s)                     Bank of New York (Nominees) Limited 
  (if different from 3.):(iv)                                      (as nominee for AGE) 
------------------------------------------  ------------------------------------------- 
 5. Date of the transaction and date                                       17 June 2013 
  on 
  which the threshold is crossed 
  or 
  reached: (v) 
------------------------------------------  ------------------------------------------- 
 6. Date on which issuer notified:                                         20 June 2013 
------------------------------------------  ------------------------------------------- 
 7. Threshold(s) that is/are crossed                                     Below 11%--AGE 
  or                                                          Below 18%--Abingworth LLP 
  reached: (vi, vii) 
------------------------------------------  ------------------------------------------- 
 
 
 
 8. Notified details: Abingworth LLP 
------------------------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------------------------------ 
 Class/type       Situation previous                    Resulting situation after the triggering 
  of               to the triggering                     transaction 
  shares           transaction 
 
  if possible 
  using 
  the ISIN CODE 
---------------  ------------------------------------  ----------------------------------------------------------------- 
                  Number           Number               Number     Number of voting         % of voting rights 
                   of               of                  of          rights                   (x) 
                   Shares           Voting              shares 
                                    Rights 
---------------  ---------------  -------------------  ---------  -----------------------  ----------------------------- 
                                                        Direct     Direct       Indirect    Direct         Indirect 
                                                                    (xi)         (xii) 
---------------    ----  -------  ------  -----  ----  ---------  -----------  ----------  -------------  -------------- 
 Lombard 
 Medical 
 Technologies 
 PLC 
 ISIN 
 (GB00B0Q5QP56) 
 20p Ords                          5,714,285                                    7,984,725                  17.85% 
                 ---------------  -------------------  ---------  -----------  ----------  -------------  -------------- 
 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of financial        Expiration       Exercise/                    Number of voting             % of voting 
  instrument               date (xiii)      Conversion Period            rights that may              rights 
                                            (xiv)                        be 
                                                                         acquired if the 
                                                                         instrument is 
                                                                         exercised/ converted. 
-----------------------  ---------------  ---------------------------  ---------------------------  -------------------- 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
------------------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------------------ 
 Type of            Exercise       Expiration     Exercise/        Number of voting             % of voting rights 
 financial           price          date (xvii)    Conversion       rights instrument            (xix, xx) 
 instrument                                        period           refers to 
                                                   (xviii) 
-----------------  -------------  -------------  ---------------  ---------------------------  ------------------------- 
                                                                                                Nominal       Delta 
-----------------  -------------  -------------  ---------------  ---------------------------  ------------  ----------- 
 
 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------------------ 
 Number of voting rights                                         Percentage of voting rights 
--------------------------------------------------------------  -------------------------------------------------------- 
 7,984,725                                                       17.85% 
--------------------------------------------------------------  -------------------------------------------------------- 
 
 
 
 8. Notified details: Abingworth Bioventures V Co-Invest Growth Equity 
  Fund LP 
-------------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
-------------------------------------------------------------------------------------------------------------------------- 
 Class/type       Situation previous                  Resulting situation after the triggering 
  of               to the triggering                   transaction 
  shares           transaction 
 
  if possible 
  using 
  the ISIN CODE 
---------------  ----------------------------------  --------------------------------------------------------------------- 
                  Number          Number              Number        Number of voting         % of voting rights 
                   of              of                  of shares     rights                   (x) 
                   Shares          Voting 
                                   Rights 
---------------  --------------  ------------------  ------------  -----------------------  ------------------------------ 
                                                      Direct        Direct        Indirect   Direct           Indirect 
                                                                     (xi)          (xii) 
---------------    ---  -------  ------  -----  ---  ------------  ------------  ---------  ---------------  ------------- 
 Lombard 
 Medical 
 Technologies 
 PLC 
 ISIN 
 (GB00B0Q5QP56) 
 20 p Ords        3,428,571       3,428,571           4,790,835     4,790,835                10.71% 
                 --------------  ------------------  ------------  ------------  ---------  ---------------  ------------- 
 
 
 B: Qualifying Financial Instruments 
-------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------------------- 
 Type of financial       Expiration       Exercise/                      Number of voting               % of voting 
  instrument              date (xiii)      Conversion Period              rights that may                rights 
                                           (xiv)                          be 
                                                                          acquired if the 
                                                                          instrument is 
                                                                          exercised/ converted. 
----------------------  ---------------  -----------------------------  -----------------------------  ------------------- 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
-------------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
-------------------------------------------------------------------------------------------------------------------------- 
 Type of            Exercise      Expiration     Exercise/          Number of voting              % of voting rights 
 financial           price         date (xvii)    Conversion         rights instrument             (xix, xx) 
 instrument                                       period             refers to 
                                                  (xviii) 
-----------------  ------------  -------------  -----------------  ----------------------------  ------------------------- 
                                                                                                  Nominal        Delta 
-----------------  ------------  -------------  -----------------  ----------------------------  -------------  ---------- 
 
 
 Total (A+B+C) 
-------------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                          Percentage of voting rights 
---------------------------------------------------------------  --------------------------------------------------------- 
 4,790,835                                                        10.71% 
---------------------------------------------------------------  --------------------------------------------------------- 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
-------------------------------------------------------------------------------------------------------------------------- 
                                                     Abingworth Bioventures V Co-Invest Growth Equity Fund LP (which holds 
                                                      4,790,835 shares in the company (10.71%)) and Abingworth Bioventures 
                                               V LP (which holds 3,193,890 shares in the company (7.14%)) are both managed 
                                                                                                        by Abingworth LLP. 
 
 Proxy Voting: 
-------------------------------------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-------------------------------------------------------------------------------  ----------------------------------------- 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
-------------------------------------------------------------------------------  ----------------------------------------- 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
-------------------------------------------------------------------------------  ----------------------------------------- 
 
 
  13. Additional information: 
---------------------------------------------------------------  --------------------------------------------------------- 
 14. Contact name:                                                                                              John Heard 
---------------------------------------------------------------  --------------------------------------------------------- 
 15. Contact telephone number:                                                                               0207 534 1500 
---------------------------------------------------------------  --------------------------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUAURRORANUAR